Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.

ABSTRACT

Diabetes mellitus (DM) and hyperglycemia are known predictors of adverse outcome in different tumor entities. The present study investigated the effect of DM and pre-surgery blood glucose levels on cancer specific survival (CSS), overall survival (OS), and disease-free survival (DFS) in non-metastatic soft tissue sarcoma (STS) patients. A total of 475 STS patients who underwent curative resection were included in this retrospective study. CSS, DFS, and OS were assessed using Kaplan-Meier curves. The association between pre-existing DM as well as mean pre-surgery blood glucose levels and all 3 survival endpoints was analyzed using Cox-hazard proportional (for OS and DFS) and competing risk regression models (for CSS). In unadjusted analysis, DM was significantly associated with adverse CSS (sub-hazard ratio [SHR] 2.14, 95% confidence interval [CI] 1.18-3.90, p = 0.013) and OS (hazard ratio [HR] 2.05, 95% CI 1.28-3.28) and remained significant after adjusting for established prognostic factors (CSS adjusted SHR 2.33, 95% CI 1.21-4.49, p = 0.012; OS adjusted HR 1.96, 95% CI 1.17-3.28, p = 0.010), respectively. There was no significant association of DM with DFS (p = 0.149). The mean pre-surgery glucose levels were not significantly associated with inferior outcome (CSS p = 0.510, OS p = 0.382 and DFS p = 0.786). This study shows, that DM represents a negative prognostic factor for clinical outcome in STS patients after curative resection.